About
Medibio (ASX: MEB), is an evidence-based medical technology company that will radically change how mental health care is delivered through objective, data driven assessment & management. Mental health represents the largest clinical problem today with an estimated 350M people world-wide suffering from...
Medibio (ASX: MEB), is an evidence-based medical technology company that will radically change how mental health care is delivered through objective, data driven assessment & management. Mental health represents the largest clinical problem today with an estimated 350M people world-wide suffering from depression. Given the subjective nature of the clinical assessments, less than 10% of patients receive optimal therapy on initial assessment. To address the clinical need, Medibio has developed an analytic platform that utilizes patented (and patent pending) panel of circadian, sleep and autonomic system biomarkers to objectively quantify and characterize mental illness. Medibio has a rich portfolio of products to address broad spectrum mental health with strong foundation IP. Medibio’s first product, a depression diagnostic aid, is being validated in clinical studies undertaken by Johns Hopkins University School of Medicine and The University of Ottawa, among others. The clinical trials will support Medibio’s application to become the first FDA approved, objective, and evidence based approach to the diagnosis of mental health disorders. Located in Melbourne (Vic) Medibio is listed on the Australian Securities Exchange Ltd. Medibio Limited (ASX: MEB) was previously named BioProspect Limited (ASX: BPO). The company changed its name on 1 December 2014 as part of a corporate transformation, with new assets, a new Board and new management.
  • 7
    Jun
    17
    News Release
    Independent researchers present first data validating Medibio’s technology at the prestigious “Sleep 2017”
  • 6
    Jun
    17
    News Release
    Medibio Limited Begins Trading on OTCQB Under Ticker Symbol MDBIF
  • 5
    Jun
    17
    News Release
    Michael Phelps, World Champion Athlete and Mental Health Advocate, Appointed to Medibio Board of Directors
  • 5
    Jun
    17
    Company Presentation
    Medibio Investor Presentation for US roadshow
  • 17
    May
    17
    News Release
    Demand for Medibio’s corporate wellness technology results in second commercial agreement with Australian Corporate Wellness provider
  • 9
    May
    17
    News Release
    Medibio Signs Strategic Joint Development Agreement with Mayo Clinic
  • 27
    Apr
    17
    News Release
    Medibio: Quarterly Update and Message from new CEO of Medibio Limited
  • 20
    Apr
    17
    News Release
    Medibio appoints experienced US based med-tech CFO
  • 10
    Apr
    17
    News Release
    Medibio enters fully funded Paediatric mental illness diagnostic research Joint Venture
  • 20
    Mar
    17
    Company Presentation
    Medibio Overview Presentation March 2017
  • 20
    Mar
    17
    News Release
    Medibio Company Update and Investor Presentations
  • 16
    Feb
    17
    News Release
    Medibio appoints US med-tech veteran as CEO and Managing Director
  • 10
    Feb
    17
    Equity Research
    Medibio (ASX:MEB) Research Update
  • 1
    Feb
    17
    News Release
    Appointement of Non Executive Director and Advisory Board Changes
  • 31
    Jan
    17
    News Release
    Medibio Quarterly ASX Update
  • 30
    Jan
    17
    News Release
    Medibio Early Redemption of Convertible Note
  • 25
    Jan
    17
    News Release
    Medibio collaborates with Emory University on PTSD research
  • 31
    Dec
    16
    Corporate Update
    Medibio investor newsletter and season's greetings
  • 20
    Dec
    16
    News Release
    Medibio’s Depression Diagnostic demonstrates excellent performance in the pilot phase of its US Validation Study
  • 29
    Nov
    16
    Company Presentation
    Medibio AGM Presentation
  • 23
    Nov
    16
    News Release
    Medibio enters into binding integration and value-added reseller agreement with Medtronic
  • 18
    Nov
    16
    News Release
    Medibio raises $13.5m to accelerate growth
  • 2
    Nov
    16
    News Release
    Medibio: University of Ottawa Depression Study improves accuracy rate to an outstanding 86% in a far larger sample
  • 31
    Oct
    16
    Corporate Update
    Medibio Quarterly Activities and Cashflow Report
  • 30
    Oct
    16
    Corporate Update
    Medibio Notice of Annual General Meeting/Proxy Form
  • 30
    Oct
    16
    Corporate Update
    Medibio newsletter to shareholders
  • 14
    Oct
    16
    News Release
    Medibio Receipt of $3,074,224 R&D Tax Incentive Refund
  • 10
    Oct
    16
    News Release
    Medibio Annual Report 2016
  • 10
    Oct
    16
    News Release
    Medibio Funding Update
  • 30
    Sep
    16
    News Release
    Medibio Directors Resignation
  • 15
    Sep
    16
    News Release
    Medibio and Monash groundbreaking partnership on innovation for sleep and mental health solution
  • 17
    Aug
    16
    News Release
    Medibio partners with Sydney University Brain Mind Centre on clinical study for corporate workplace stress assessment
  • 8
    Aug
    16
    News Release
    Breakthrough validation of Medibio’s algorithm for diagnosing depression using independent clinical data
  • 5
    Aug
    16
    News Release
    Medibio Trading Halt Request
  • 31
    Jul
    16
    News Release
    Medibio Q2 Quarterly Report (1 Aug 2016)
  • 7
    Jul
    16
    Company Presentation
    Medibio Investor Presentation
  • 24
    Jun
    16
    News Release
    Medibio’s Advanced Analytics Cloud Solution Breaks New Ground in Sleep Analysis
  • 30
    May
    16
    News Release
    Medibio’s first commercial pilot study a success
  • 30
    Apr
    16
    News Release
    Medibio Quarterly Report March 2016
  • 29
    Apr
    16
    News Release
    Medibio New issue announcement, application for quotation of additional securities and agreement
  • 29
    Apr
    16
    News Release
    Medibio Notice Given Under Section 708A (5) Of The Corporations Act
  • 21
    Apr
    16
    News Release
    Medibio letter to shareholders
  • 19
    Apr
    16
    News Release
    Medibio Acquires Key IP
  • 4
    Apr
    16
    Company Presentation
    Medibio Investor Presentation April 2016
  • 1
    Apr
    16
    News Release
    Medibio Completes Successful Pre-Submission Meeting with the US FDA
  • 28
    Mar
    16
    Equity Research
    Medibio Ltd. (ASX:MEB) Research Update
  • 17
    Mar
    16
    Company Presentation
    Medibio Company Presentation: BioMelbourne Conference on Wireless and Wearable Technology March 2016
  • 11
    Mar
    16
    News Release
    Leading US Institutions provide Medibio 10,000 new physiological data sets which will significantly advance validation and drive commercial outcomes
  • 7
    Mar
    16
    News Release
    Medibio: Swinburne Software Labs trial success with Apple Watch® and FITBIT® for Medibio’s Stress app
  • 28
    Feb
    16
    News Release
    Medibio (ASX:MEB) Half-Yearly Report to 31 December 2015
  • 16
    Feb
    16
    News Release
    Medibio: First commercial pilot study with Wellness Channel Partner commences
  • 9
    Feb
    16
    News Release
    Medibio partners with Swinburne University for Evaluation of Wearable device applications for Mental Health
  • 31
    Jan
    16
    News Release
    Medibio Appendix 3B Amendment and re-lodgement
  • 31
    Jan
    16
    News Release
    Medibio Quarterly Report December 2015
  • 27
    Jan
    16
    News Release
    Medibio Ltd appoints highly distinguished US medical expert, Franklyn G. Prendergast, M.D., Ph.D., as a Director
  • 27
    Jan
    16
    News Release
    Medibio Appendix 3X Initial Director’s Interest Notice
  • 19
    Jan
    16
    Equity Research
    Medibio (ASX:MEB) Research Update
  • 14
    Jan
    16
    News Release
    Medibio Receipt of R & D Tax Incentive Refund
  • 23
    Dec
    15
    News Release
    Medibio and WellNovation MOU takes stress diagnostic to Saudi Arabia and Gulf Cooperation Council
  • 22
    Dec
    15
    News Release
    Medibio enters into MOU with Medtronic
  • 27
    Nov
    15
    News Release
    Medibio Corporate Wellness Partner Program Commences
  • 24
    Nov
    15
    Equity Research
    Medibio Ltd. (ASX:MEB) Research Update
  • 24
    Nov
    15
    News Release
    Medibio’s Study With Johns Hopkins University School Of Medicine Receives IRB Approval
  • 17
    Nov
    15
    Company Presentation
    Medibio Investor Presentation November 2015
  • 10
    Nov
    15
    Corporate Update
    Fosters Stockbroking Intiates Research Coverage On Medibio
  • 3
    Nov
    15
    News Release
    Medibio Quarterly Report For The Period Ending 30 Sept 15
  • 28
    Oct
    15
    News Release
    Medibio Annual Report 2015
  • 12
    Oct
    15
    News Release
    Medibio collaborates with University of Ottawa on research
  • 1
    Oct
    15
    News Release
    Medibio Key to Disclosures Corporate Governance Council Principles and Recommendations
  • 25
    Sep
    15
    News Release
    Medibio launches Corporate Wellness Partner Program for its Corporate Stress product
  • 3
    Sep
    15
    News Release
    MediBio capital raising of AU$3.1 million to accelerate growth
  • 27
    Aug
    15
    News Release
    Medibio signs first commercial agreement for its corporate stress product
  • 17
    Aug
    15
    News Release
    Medibio reports strong response from US Corporates and Universities; US research coverage
  • 17
    Aug
    15
    News Release
    MEB June 2015 Quarter Operations Report
  • 13
    Aug
    15
    Equity Research
    Medibio Ltd. (ASX:MEB) Research Initiation
  • 15
    Jul
    15
    News Release
    Medibio lodges provisional patent for improved objective diagnostic for depression and other medical conditions
  • 2
    Jul
    15
    News Release
    Medibio lodges provisional patent covering stress breakthrough.
  • 16
    Jun
    15
    News Release
    Medibio Limited develops ground-breaking test for stress measurement and its impact on health and wellbeing
  • 15
    Jun
    15
    Company Presentation
    Medibio Medical Presentation June 2015
  • 15
    Jun
    15
    Company Presentation
    Medibio Investor Presentation June 2015
  • 13
    May
    15
    News Release
    Medibio is pleased to report on its activities for the March 2015 quarter.
  • 11
    May
    15
    News Release
    Medibio Ltd processes first participant in UNSW/Black Dog Institute depression test validation study